Pricing

Immunovant

4 followers

‌

Immunovant, Inc. is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases. Immunovant is developing IMVT-1401, a novel, fully human anti-FcRn monoclonal antibody, as a subcutaneous injection for the treatment of autoimmune diseases mediated... Read more

Industries

Headquarters

New York, United States

Employees

Links

Org chart

Chief Executive Officer

Peter Salzmann

Collapse

Chief Financial Officer

Chief Medical Officer

Julia G. Butchko

Chief Development Officer

Chief Legal Officer & Corporate Secretary

Chief Technology Officer

VP, Biostatistics & Programming

VP, Global Regulatory Affairs

VP, Marketing

VP, Quality

VP, CMC Project Management, Operations & Clinical Supply

VP, Clinical Development

Rebecca Merlina

Svp, Global Head Of Quality

Teams

Clinical Operations Team

20 members

Vice Presidents

10 members

Leadership Team

9 members

Similar companies

4D Molecular Therapeutics

3 followers

Pivot Bio

2 followers

Quantum-Si

2 followers

Jnana Therapeutics

1 follower

Sonoma Biotherapeutics

1 follower

Cytokinetics

11 followers

Neurocrine Biosciences

5 followers

Coherus BioSciences

5 followers

Lighthouse Worldwide Solutions

1 follower

Axsome Therapeutics

2 followers

BridgeBio

2 followers

Explore companies